Acanthoma planoepitheliale hyperkeratoticum, lesions associated with BRAF inhibitor in metastatic melanoma

J Eur Acad Dermatol Venereol. 2018 Feb;32(2):e83-e84. doi: 10.1111/jdv.14540. Epub 2017 Sep 22.

Authors

M Sokołowska-Wojdyło¹, B Olszewska¹, M Sobjanek¹, M Sławińska¹, K Sosińska-Mielcarek², W Biernat³, R Nowicki¹

Affiliations

¹ Department of Dermatology, Venerology and Allergology, Medical University of Gdańsk, Gdańsk, Poland.
² Department of Oncology and Radiotherapy, Medical University of Gdańsk, Gdańsk, Poland.
³ Department of Pathology, Medical University of Gdańsk, Gdańsk, Poland.

PMID: 28857272
DOI: 10.1111/jdv.14540

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Acanthoma / chemically induced*
Acanthoma / pathology
Aged
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
Female
Humans
Imidazoles / administration & dosage
Imidazoles / adverse effects*
Melanoma / drug therapy*
Melanoma / secondary
Oximes / administration & dosage
Oximes / adverse effects*
Pyridones / administration & dosage
Pyrimidinones / administration & dosage
Skin Neoplasms / drug therapy*
Skin Neoplasms / pathology

Substances

Imidazoles
Oximes
Pyridones
Pyrimidinones
trametinib
dabrafenib